Company Filing History:
Years Active: 2025
Title: John K Kawooya: Innovator in Bispecific Antibodies
Introduction
John K Kawooya is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work has led to the creation of a unique patent that enhances the functionality of therapeutic molecules.
Latest Patents
Kawooya holds a patent for "Bispecific antibodies with cleavable C-terminal charge-paired tags." This invention is directed to a CH3-containing molecule comprising a first polypeptide with a CH3 domain and a negatively charged domain, as well as a second polypeptide with a CH3 domain and a positively charged domain. The patent outlines methods for conjugating synthetic molecules to a multi-specific antigen binding molecule, showcasing Kawooya's expertise in molecular design.
Career Highlights
Throughout his career, Kawooya has been associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other talented professionals in the field, further advancing the development of innovative therapeutic solutions.
Collaborations
Some of Kawooya's notable coworkers include Alex W Jacobitz and Christopher Mohr. Their collaborative efforts contribute to the dynamic research environment at Amgen, fostering innovation and the development of groundbreaking therapies.
Conclusion
John K Kawooya's contributions to the field of biotechnology, particularly through his patent on bispecific antibodies, highlight his role as an influential inventor. His work continues to impact the development of advanced therapeutic solutions in the industry.